MEDORPHAN

This brand name is authorized in Cyprus

Active ingredients

The drug MEDORPHAN contains one active pharmaceutical ingredient (API):

1 Demorphan
UNII 7355X3ROTS - DEXTROMETHORPHAN

Dextromethorphan is a non-opioid antitussive drug. The major metabolite of dextromethorphan, dextrorphan, binds with high affinity to σ-receptors to produce its antitussive activity without exhibiting the classic opiate effects that occur from binding into μ- and δ-receptors. In larger than therapeutic doses, dextrorphan is also an antagonist of N-methyl-D-aspartate (NMDA) receptors.

Read about Demorphan

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
MEDORPHAN Syrup Υπουργείο Υγείας (CY) MPI, EU: SmPC
MEDORPHAN Oral solution Υπουργείο Υγείας (CY) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R05DA09 Dextromethorphan R Respiratory system → R05 Cough and cold preparations → R05D Cough suppressants, excl. combinations with expectorants → R05DA Opium alkaloids and derivatives
Discover more medicines within R05DA09

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.